Study reports high-fat diet increases the incidence of colorectal cancer

Recent research states that the occurrence of colorectal cancer is increased by a high-fat diet. Cold Spring Harbor Laboratory Fellow Semir Beyaz and associates from Harvard Medical School and Massachusetts Institute of Technology found that fat interrupts the relationship between intestinal cells and the immune cells that defend them seeking emerging tumors in mice. The relationship can be mended by reconfiguring the gut microbiome.

Study reports high-fat diet increases the incidence of colorectal cancer
A microscopic image of a normal mouse small intestine. Cells stained red express normal amounts of cell-surface tags (MHC-II) needed by immune cells to find threats like infections or cancer. High-fat diets reduce the levels of MHC-II tags in intestinal cells, and so the immune system has a harder time recognizing intestinal tumors. Image Credit: Beyaz lab.

The immune system safeguards tissues eradicating and watching out for threats. Some immune cells search for tags that differentiate between abnormal and normal cells. A tag, named MHC-II, helps target cells for annihilation.

MHC-II present in the cell surface triggers the immune system to eliminate that cell, regardless of it being worn out or about to become cancerous. Beyaz and his associates identified that MHC-II levels were inhibited in intestinal cells when mice were fed diets high in fat. Cells with decreased levels of these tags were not identified as abnormal and thus they possibly grow into tumors.

If we alter the level of these immune recognition molecules in a positive way, then the tumor will more likely be recognized by the immune cell. We hope this can be coupled with the existing strategies, such as immunotherapy, to eradicate tumors.”

Charlie Chung, Stony Brook University

Charlie Chung is a graduate student-in-residence in Beyaz’s lab. The scientists identified that a high-fat diet altered the mouse’s intestinal microbiome (the mixture of microbes in the gut). Numerous bacteria, including the ones known as Helicobacter, increase MHC-II, which might aid immune cells to identify abnormal cells.

The researchers performed a “dirty roommate” experiment where they housed mice without these bacteria along with ones that had it. The “clean” mice were infected with the Helicobacter bacteria and produced more of the MHC-II tag.

The observations suggest a novel process to boost existing immunotherapy treatments against cancer. According to Beyaz, increasing the production of MHC-II tag by drugs, diet, or modifying the microorganisms in the body can aid the immune system to identify and eliminate cancer cells.

This interaction between diet, microbes, and immune recognition has the potential to help us explain how lifestyle factors can contribute to tumor initiation, progression, or response to therapy.”

Semir Beyaz, Cold Spring Harbor Laboratory

Cancer cells employ numerous tricks to evade being identified as abnormal by the immune system; however, Beyaz believes he has identified numerous ways to outsmart them.

Journal reference:

Beyaz, S., et al. (2021) Dietary suppression of MHC class II expression in intestinal epithelial cells enhances intestinal tumorigenesis. Cell Stem Cell.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Designing Compounds for Next-Gen Antibiotics and Cancer Treatments